Page last updated: 2024-09-03
goe 5438 and Acute Liver Injury, Drug-Induced
goe 5438 has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jeong, SY; Kobayashi, T; Okamoto, T | 1 |
Other Studies
1 other study(ies) available for goe 5438 and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
NC-1500 prevents concanavalin A-induced mice hepatitis without affecting cytokine gene expression.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Concanavalin A; Dihydropyridines; Disease Models, Animal; Female; Gene Expression; Glycyrrhizic Acid; Mice; Mice, Inbred BALB C; Naphthyridines; RNA, Messenger; Tumor Necrosis Factor-alpha | 2001 |